Related Experiment Videos
Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration.
Yen Lin Chia1, Peter Salzman, Sylvia K Plevritis
1Management Science and Engineering, Terman Engineering Center, Stanford University, Stanford, CA 94305-4026, USA.
Statistical Methods in Medical Research
|December 14, 2004
Summary
Simulation-based parameter estimation simplifies complex stochastic models, like breast cancer growth, by using computer simulations to find the best model fit. This method is effective for intricate models and real-world data.
Area of Science:
- Computational Biology
- Mathematical Modeling
- Cancer Research
Background:
- Estimating parameters in complex stochastic models is challenging.
- Natural history models are crucial for understanding disease progression, such as breast cancer.
- Existing methods may struggle with the complexity of real-world biological systems.
Purpose of the Study:
- To demonstrate simulation-based parameter estimation for a breast cancer natural history model.
- To apply these methods using data from the Surveillance, Epidemiology, and End Results (SEER) registry.
- To highlight the utility of simulation in computing maximum likelihood estimators for complex models.
Main Methods:
- Developed a natural history model for breast cancer.
- Assumed tumor growth follows a geometric Brownian motion process.
- Employed simulation techniques to compute the maximum likelihood estimator (MLE).
Main Results:
- Successfully estimated model parameters using SEER registry data.
- Demonstrated that simulation provides a computationally feasible approach for parameter estimation.
- Confirmed the effectiveness of simulation for models with substantial complexity.
Conclusions:
- Simulation-based parameter estimation is a powerful and practical tool for complex stochastic models.
- This approach is well-suited for analyzing cancer natural history models.
- The method offers a straightforward way to compute estimators, facilitating deeper insights into disease dynamics.